Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
出版年份 2019 全文链接
标题
Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-04-04
DOI
10.3389/fimmu.2019.00671
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells
- (2018) Yohei Takeda et al. Innate Immunity
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues
- (2018) Richard Ming Yi Tang et al. Scientific Reports
- Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
- (2018) Yohei Takeda et al. Frontiers in Immunology
- Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
- (2018) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
- (2017) Hanna-Riikka Teppo et al. Oxidative Medicine and Cellular Longevity
- A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
- (2017) Yohei Takeda et al. Cell Reports
- Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
- (2017) Hiroaki Shime et al. OncoImmunology
- The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages
- (2017) Sumito Yoshida et al. PLoS One
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- A Safety Evaluation of a Nature-Identical l-Ergothioneine in Sprague Dawley Rats
- (2016) Palma Ann Marone et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy
- (2016) Yohei Takeda et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling
- (2015) Akira Maruyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adjuvant for vaccine immunotherapy of cancer - focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity
- (2015) Tsukasa Seya et al. CANCER SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
- (2015) Misako Matsumoto et al. Nature Communications
- Molecular Pathways: Myeloid Complicity in Cancer
- (2014) I. M. Stromnes et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Ergothioneine; antioxidant potential, physiological function and role in disease
- (2011) Irwin K. Cheah et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma
- (2011) Bicheng Zhang et al. Clinics
- The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC
- (2011) Chandra M. Ohri et al. PLoS One
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evaluation of the safety of the dietary antioxidant ergothioneine using the bacterial reverse mutation assay
- (2010) Alexander G. Schauss et al. TOXICOLOGY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started